Stomatológ 2019, 29(1):35-39 | DOI: 10.69658/sto.2019.008

Prevention of medication-related osteonecrosis of the jaw in at-risk patients undergoing dentoalveolar surgery

Katarína Mikušková*, Dagmar Statelová, Mária Janíčková, Ján Staško, Zuzana Frličková, Daniel Hvizdoš
Klinika stomatológie a maxilofaciálnej chirurgie JLF UK a UNM v Martine

The authors present their experience with prevention of MRONJ using their own protocol for MRONJ prevention in at-risk patients undergoing dentoalveolar surgery. Survey was conducted between the years 2014 - 2016.

Keywords: osteonecrosis of the maxilla, osteonecrosis of the mandible, drug osteonecrosis

Published: June 15, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mikušková K, Statelová D, Janíčková M, Staško J, Frličková Z, Hvizdoš D. Prevention of medication-related osteonecrosis of the jaw in at-risk patients undergoing dentoalveolar surgery. Stomatológ. 2019;29(1):35-39. doi: 10.69658/sto.2019.008.
Download citation

References

  1. BRAMATI, A., GIRELLI, S., FARINA, G., DAZZANI, M., C., TORRI, V., MORETTI, A., PIVA, S., DIMAIUTA, M., LA VERDE, N.: Prospective, mono-institutional study of the impact of a systematic prevention program on incidence and outcome of osteonecrosis of the jaw in patients treated with bisphosphonates for bone metastases. Journal of Bone and Mineral Metabolism. 2015, 33, 1, p. 119-124. Go to original source... Go to PubMed...
  2. FLEISHER, K., E., KONTIO, R., OTTO, S.: Antiresorptive Drug-related Osteonecrosis of the Jaw (ARONJ) - a Guide to Research. Thieme, 2016. ISBN: 978-3-905363-10-4.
  3. HEUFELDER, M., J., HENDRICKS, J., REMMERBACH, T., FRERICH, B., HEMPRICH, A., WILDE, F.: Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 2014, 117, 6, p. 429-435. Go to original source... Go to PubMed...
  4. KAWAKITA, A., YANAMOTO, S., MORISHITA, K., NARUSE, T., HAYASHIDA, S., SOUTOME, S., ROKUTANDA, S., INOKUCHI, S., MATSUO, T., UMEDA, M.: Discontinuing oral bisphosphonate therapy during dental extraction does not prevent osteonecrosis of the jaw: A multicenter retrospective study of 341 patients with propensity score matching analysis. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2017, 29, p. 522-526. Go to original source...
  5. OTTO, S., PAUTKE, CH. et al.: Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treatment Reviews. 2018, 69, p. 177-187. Go to original source... Go to PubMed...
  6. OWOSHO, A., A., LIANG, S., T., Y., SAX, A., Z., WU, K., YOM, K., S., HURYN, M., J., ESTILO, C., L.: Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018, 125, p. 440-445. Go to original source... Go to PubMed...
  7. SCHUBERT, M., KLATTE, I., LINEK, W., MÜLLER, B., DÖRING, K., ECKELT, U., HEMPRICH, A., BERGER, U., HENDRICKS, J.: The Saxon Bisphosphonate Register - Therapy and prevention of bisphosphonate-related osteonecrosis of the jaws. Oral Oncology. 2012, 48, p. 349-354. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.